Immunotherapy and allogeneic stem cells transplantation

被引：0
|
作者：
de Fontbrune, Flore Sicre [1 ]
Cavalieri, Doriane [2 ]
Leclerc, Mathieu [3 ]
Beckerich, Florence [3 ]
Maury, Sebastien [3 ]
de latour, Regis Peffault [1 ]
N-Guyen, Stephanie [4 ]
Bay, Jacques-Olivier [2 ]
机构：
[1] GH Henri Mondor, Hematol Clin & Transplantat, Creteil, France
[2] CHU Clermont Ferrand, Serv Theapie Cellulaire & Hematol Clin Adulte, Site Estaing 1,Pl Lucie Aubrac, F-63000 Clermont Ferrand, France
[3] Hop St Louis, Serv Hematol Greffe Moelle, 1 Ave Claude Vellefaux, F-75475 Paris 10, France
[4] Univ Paris 06, Univ Sorbonne, AP HP,CNRS ERL8255,Serv Hematol Clin, Ctr Immunol & Malad Infect CIMI Paris,INSERM U113, Paris, France
来源：
BULLETIN DU CANCER | 2016年 / 103卷
关键词：
HLA typing; Allogeneic transplantation; Immunotherapy; VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; DONOR LYMPHOCYTE INFUSIONS; ACUTE LYMPHOBLASTIC-LEUKEMIA; CORD BLOOD TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; MINOR HISTOCOMPATIBILITY ANTIGENS; DE-THERAPIE-CELLULAIRE; REDUCED-INTENSITY; T-CELLS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Allogeneic stem cell transplantations represent perfect example of immunotherapy. Its positive aspects are due to the graft versus tumor effect. Unfortunately, this therapeutic advantage is usually associated with graft versus host effects. While the mechanism of these two graft reactions remain unclear, this is possible to modulate these immunologic effects. The type of conditioning regimen, the source of donor and the use of donor cells after the transplantation may influence the toxicity and the tumor response, leading to a better optimization of the procedure. This paper is presenting all the parameters which may contribute to improve allogeneic stem cell transplantations.
引用
收藏
页码：S164 / S174
页数：11
相关论文
共 50 条
  • [31] Gene therapy in the transplantation of allogeneic organs and stem cells
    Horn, Peter A.
    Figueiredo, Constanca
    Kiem, Hans-Peter
    CURRENT GENE THERAPY, 2007, 7 (06) : 458 - 468
  • [32] Purification of CD4+ T Cells for Adoptive Immunotherapy after Allogeneic Hematopoietic Stem Cell Transplantation
    Klyuchnikov, Evgeny
    Sputtek, Andreas
    Slesarchuk, Olga
    Lioznov, Michael
    Stuebig, Thomas
    Bacher, Ulrike
    Amtsfeld, Gitta
    Merle, Edeltraut
    Reckhaus, Marie-Luise
    Fehse, Boris
    Wolschke, Christine
    Adjalle, Raissa
    Ayuk, Francis
    Zander, Axel
    Kroeger, Nicolaus
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (03) : 374 - 383
  • [33] Purification of CD4+ T cells for adoptive immunotherapy after allogeneic hematopoietic stem cell transplantation
    Klyuchnikov, E.
    Sputtek, A.
    Slesarchuk, O.
    Lioznov, M.
    Stuebig, T.
    Becher, U.
    Amtsfeld, G.
    Merle, E.
    Reckhaus, M-L
    Fehse, B.
    Wolschke, C.
    Adjalle, R.
    Ayuk, F.
    Zander, A.
    Kroger, N.
    ONKOLOGIE, 2010, 33 : 163 - 163
  • [34] Dendritic cells in allogeneic hematopoietic stem cell transplantation
    Nachbaur, D
    Kircher, B
    LEUKEMIA & LYMPHOMA, 2005, 46 (10) : 1387 - 1396
  • [35] Peripheral blood stem cells for allogeneic transplantation: A review
    Cutler, C
    Antin, JH
    STEM CELLS, 2001, 19 (02) : 108 - 117
  • [36] Umbilical cord blood stem cells for allogeneic transplantation
    Kobzeva, I.
    Podkolzina, E.
    Karpova, E.
    Lebedeva, L.
    Kruglova, Y.
    Skorobogatova, E. V.
    Paina, O.
    Astrelina, T.
    Yakovleva, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S134 - S134
  • [37] Allogeneic transplantation of blood stem cells: Coming of age?
    Peter Dreger
    Norbert Schmitz
    Annals of Hematology, 2001, 80 : 127 - 136
  • [38] New immunotherapy-based approach in allogeneic hematopoietic stem cell transplantation
    Maeda, Yoshinobu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 107 (02) : 129 - 129
  • [39] Nonmyeloablative stem cell transplantation for solid tumors: Expanding the application of allogeneic immunotherapy
    Childs, R
    Barrat, J
    SEMINARS IN HEMATOLOGY, 2002, 39 (01) : 63 - 71
  • [40] Adoptive immunotherapy for uncontrolled adenovirus infection after allogeneic stem cell transplantation
    Destras, G.
    Gaymard, A.
    Fossard, G.
    Ducastelle, S.
    Laroye, C.
    Ader, F.
    Frobert, E.
    INFECTIOUS DISEASES NOW, 2021, 51 (07): : 614 - 617
12345